Bar Levy: What Can We Do to Promote Early Detection of Endometrial Cancer? Oncodaily
Annexin A2 (ANXA2) is a calcium-dependent protein with high affinity for phospholipids, and its multifunctional nature has drawn increasing attention in the onset and progression of various disorders of the …
Endometriosis (EM) is a prevalent gynecological disorder linked to pelvic pain, menstrual disturbances, and infertility. Despite its clinical burden, the molecular mechanisms underlying EM remain elusive, necessitating the discovery of …
Endometriosis is a chronic estrogen-dependent disorder affecting approximately 10% of women of reproductive age. Increasing epidemiological and molecular evidence indicates that it may represent a precursor condition for a subset …
Maine braces for another tick season amid promising Lyme vaccine trials newscentermaine.com
GSK ovarian and womb cancer drug shows promise in early trial FemTech World
Background/Objective: RNA modifications, including N6-methyladenosine (m6A), 5-methylcytosine (m5C), 7-methylguanosine (m7G), N1-methyladenosine (m1A), pseudouridine (Ψ), N4-acetylcytidine (ac4C), 5-methoxycarbonylmethyl-2-thiouridine (mcm5s2U) and adenosine-to-inosine (A-to-I) editing, constitute a critical layer of post-transcriptional regulation that …
GSK reports promising early results in ovarian and womb cancer drug trial The Guardian
GSK sees blockbuster potential in targeted cancer therapy after promising early data KELO-AM
GSK sees blockbuster potential in targeted cancer therapy after promising early data KFGO